Home Life Science Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production
Life Science

Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production

Share
Share
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announ
Thank you for your interest in The Registry. You must Subscribe or Log In to read the rest of this content.
Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

Seattle Life Science Vacancy Climbs to 22.8% as More Than 500,000 SQFT of New Product Delivers

Two major projects enter Greater Seattle’s lab market in 2025 with moderate...

OHSU’s $650MM, 530,000 SQFT Vista Pavilion in Portland Completed On Time and Under Budget

The 14-story hospital tower, one of Oregon’s most complex healthcare construction projects,...

Intercontinental Real Estate Corporation Sells 228,000 SQFT 222 Fifth Life Science Property in Seattle for $50MM

Former Phoenix Suns owner’s affiliate purchases 222 Fifth, a 228,000-square-foot biotech hub...

Social Media Auto Publish Powered By : XYZScripts.com